ArticleTranslational cancer research2021
Optimum adjuvant trastuzumab duration for human epidermal growth factor receptor-2 positive breast cancer: a network meta-analysis of randomized trials.
Ji Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.